News - Gentium, Nephrology and Hepatology


Popular Filters

Italy’s Gentium accepts $1 billion takeover offer from Jazz Pharma


Ireland-headquartered drugmaker Jazz Pharmaceuticals has entered into a definitive agreement to acquire…

defibrotideDefitelioGentiumItalyJazz PharmaceuticalsMergers & AcquisitionsNephrology and HepatologyPharmaceuticalRare diseases

Positive EU regulatory news for Alexza and Ferrer, but not Gentium


USA-based Alexza Pharmaceuticals (Nasdaq: ALXA) and Spanish partner Grupo Ferrer Internacional have received…

AdasuveAlexza PharmaceuticalBiotechnologydefibrotideEuropeFerrer InternacionalGentiumNephrology and HepatologyNeurologicalPharmaceuticalRegulation

PharmaSwiss to distribute Gentium's defibrotide in CEE and other countries


Italian drugmaker Gentium SpA (Nasdaq: GENT) has appointed PharmaSwiss, a division of Canada's Valeant…

defibrotideEuropeGentiumLicensingNephrology and HepatologyPharmaceuticalPharmaSwissValeant Pharmaceuticals

Back to top